Pharmaceuticals

Retinal disease prevalence is boosting the Jetrea Market 2026

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Jetrea Market Over The Period 2026–2030?

The historical expansion was driven by the inherent limitations of surgical vitrectomy, a growing occurrence of age-related eye conditions, the initial clinical validation of ocriplasmin, an escalation in awareness among ophthalmologists, and the increasing requirement for non-surgical approaches to retinal interventions.

The anticipated expansion during the forecast period is connected to a globally aging demographic, an increase in specialized retinal clinics, more extensive screening for macular conditions, a preference for clinic-based treatments, and ongoing innovation in ophthalmic enzymes. Key developments expected during this timeframe include the increasing uptake of pharmacologic vitreolysis, a growing preference for less invasive retinal procedures, a rise in the diagnosis of vitreomacular disorders, a transition towards enzyme-centric ophthalmic therapies, and the broadening of outpatient retinal care.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20115&type=smp

What Drivers Are Expected To Influence The Jetrea Market During The Forecast Period?

The rising occurrence of retinal diseases is anticipated to boost the expansion of the jetrea market in the coming period. These conditions involve the retina, the eye’s light-sensitive tissue, and can cause vision loss or blindness without proper treatment. This growing prevalence stems from an aging global population, an increase in diabetes cases, and heightened exposure to risk factors such as high blood pressure and shifts in lifestyle. Jetrea (ocriplasmin) provides a treatment option for vitreomacular traction and macular holes, thereby helping to manage particular retinal disorders linked to the growing incidence of age-related and diabetes-related eye problems. For example, in May 2024, The Royal College of Ophthalmologists, a UK-based public college, reported that the rate of vision impairment and blindness due to age-related macular degeneration (AMD) is forecast to increase to 29.7% by 2050, from 23.1% in 2024, with the number of affected individuals expanding from about 445,809 to an estimated 1.23 million. Consequently, the expanding occurrence of retinal diseases propels the jetrea market.

How Is The Jetrea Market Divided Into Its Major Segments?

The jetrea market covered in this report is segmented –

1) By Indication: Vitreomacular Traction, Symptomatoc Vitreomacular Adhesion, Combination Therapy

2) By Patient Demographics: Adult Patients, Elderly Patients, High-Risk Groups

3) By Distribution Channel: Direct Sales, Pharmaceutical Wholesalers, Online Pharmacies, International Markets

4) By End User: Ophthalmologists, Hospitals And Clinics, Outpatient Surgical Centres, Research Institutions

Who Are The Prominent Organizations Shaping The Jetrea Market?

Major companies operating in the jetrea market are Oxurion NV (Formerly ThromboGenics Inc.)

Read the full jetrea market report here:

https://www.thebusinessresearchcompany.com/report/jetrea-global-market-report

Which Region Is Forecast To Lead The Jetrea Market In Terms Of Market Size?

North America was the largest region in the Jetrea market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the jetrea market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Jetrea Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20115&type=smp

Browse Through More Reports Similar to the Global Jetrea Market 2026, By The Business Research Company

Business Jets Market Report 2026

https://www.thebusinessresearchcompany.com/report/business-jets-global-market-report

Jet Fuel Market Report 2026

https://www.thebusinessresearchcompany.com/report/jet-fuel-global-market-report

Very Light Jet Market Report 2026

https://www.thebusinessresearchcompany.com/report/very-light-jet-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795